15-70667237-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_018003.4(UACA):c.3447G>A(p.Val1149=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00209 in 1,613,906 control chromosomes in the GnomAD database, including 63 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.011 ( 26 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 37 hom. )
Consequence
UACA
NM_018003.4 synonymous
NM_018003.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0510
Genes affected
UACA (HGNC:15947): (uveal autoantigen with coiled-coil domains and ankyrin repeats) This gene encodes a protein that contains ankyrin repeats and coiled coil domains and likely plays a role in apoptosis. Studies in rodents have implicated the encoded protein in the stimulation of apoptosis and the regulation of mammary gland involution, in which the mammary gland returns to its pre-pregnant state. This protein has also been proposed to negatively regulate apoptosis based on experiments in human cell lines in which the protein was shown to interact with PRKC apoptosis WT1 regulator protein, also known as PAR-4, and inhibit translocation of the PAR-4 receptor. Autoantibodies to this protein have been identified in human patients with panuveitis and Graves' disease. Differential expression of this gene has been observed in various human cancers. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 15-70667237-C-T is Benign according to our data. Variant chr15-70667237-C-T is described in ClinVar as [Benign]. Clinvar id is 3056178.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.051 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0112 (1698/152266) while in subpopulation AFR AF= 0.0396 (1643/41540). AF 95% confidence interval is 0.038. There are 26 homozygotes in gnomad4. There are 813 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 26 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UACA | NM_018003.4 | c.3447G>A | p.Val1149= | synonymous_variant | 16/19 | ENST00000322954.11 | NP_060473.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UACA | ENST00000322954.11 | c.3447G>A | p.Val1149= | synonymous_variant | 16/19 | 1 | NM_018003.4 | ENSP00000314556 | P1 | |
UACA | ENST00000539319.5 | c.3120G>A | p.Val1040= | synonymous_variant | 13/16 | 1 | ENSP00000438667 | |||
UACA | ENST00000379983.6 | c.3408G>A | p.Val1136= | synonymous_variant | 16/19 | 5 | ENSP00000369319 | |||
UACA | ENST00000560441.5 | c.3402G>A | p.Val1134= | synonymous_variant | 16/19 | 5 | ENSP00000454018 |
Frequencies
GnomAD3 genomes AF: 0.0111 AC: 1694AN: 152148Hom.: 26 Cov.: 32
GnomAD3 genomes
AF:
AC:
1694
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00295 AC: 737AN: 250224Hom.: 16 AF XY: 0.00213 AC XY: 288AN XY: 135240
GnomAD3 exomes
AF:
AC:
737
AN:
250224
Hom.:
AF XY:
AC XY:
288
AN XY:
135240
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00115 AC: 1680AN: 1461640Hom.: 37 Cov.: 31 AF XY: 0.00101 AC XY: 737AN XY: 727112
GnomAD4 exome
AF:
AC:
1680
AN:
1461640
Hom.:
Cov.:
31
AF XY:
AC XY:
737
AN XY:
727112
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0112 AC: 1698AN: 152266Hom.: 26 Cov.: 32 AF XY: 0.0109 AC XY: 813AN XY: 74454
GnomAD4 genome
AF:
AC:
1698
AN:
152266
Hom.:
Cov.:
32
AF XY:
AC XY:
813
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
UACA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at